受强制性开放获取政策约束的文章 - Yiming Zhong了解详情
无法在其他位置公开访问的文章：2 篇
The B-cell receptor pathway: a critical component of healthy and malignant immune biology
Y Zhong, JC Byrd, JA Dubovsky
Seminars in hematology 51 (3), 206-218, 2014
强制性开放获取政策： US National Institutes of Health
Atypical teratoid rhabdoid tumor in a child with neurofibromatosis type 2: A novel dual diagnosis
C Kotch, MJ Fisher, F Lin, Y Zhong, D Gallo, Z Fan, J Chen, M Santi, ...
Cancer Genetics 262, 1-4, 2022
强制性开放获取政策： US National Institutes of Health
可在其他位置公开访问的文章：19 篇
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes
JA Dubovsky, KA Beckwith, G Natarajan, JA Woyach, S Jaglowski, ...
Blood, The Journal of the American Society of Hematology 122 (15), 2539-2549, 2013
强制性开放获取政策： US National Institutes of Health
Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia
R Lapalombella, Q Sun, K Williams, L Tangeman, S Jha, Y Zhong, ...
Blood, The Journal of the American Society of Hematology 120 (23), 4621-4634, 2012
强制性开放获取政策： US National Institutes of Health
Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy
JA Woyach, K Smucker, LL Smith, A Lozanski, Y Zhong, AS Ruppert, ...
Blood, The Journal of the American Society of Hematology 123 (12), 1810-1817, 2014
强制性开放获取政策： US National Institutes of Health
Ibrutinib treatment ameliorates murine chronic graft-versus-host disease
JA Dubovsky, R Flynn, J Du, BK Harrington, Y Zhong, B Kaffenberger, ...
The Journal of clinical investigation 124 (11), 4867-4876, 2014
强制性开放获取政策： US National Institutes of Health
Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation
TM Liu, JA Woyach, Y Zhong, A Lozanski, G Lozanski, S Dong, E Strattan, ...
Blood, The Journal of the American Society of Hematology 126 (1), 61-68, 2015
强制性开放获取政策： US National Institutes of Health
Myeloid-derived suppressor cells express Bruton's tyrosine kinase and can be depleted in tumor-bearing hosts by ibrutinib treatment
A Stiff, P Trikha, R Wesolowski, K Kendra, V Hsu, S Uppati, E McMichael, ...
Cancer research 76 (8), 2125-2136, 2016
强制性开放获取政策： US National Institutes of Health
IPI-145 antagonizes intrinsic and extrinsic survival signals in chronic lymphocytic leukemia cells
S Dong, D Guinn, JA Dubovsky, Y Zhong, A Lehman, J Kutok, JA Woyach, ...
Blood, The Journal of the American Society of Hematology 124 (24), 3583-3586, 2014
强制性开放获取政策： US National Institutes of Health
Selinexor suppresses downstream effectors of B-cell activation, proliferation and migration in chronic lymphocytic leukemia cells
Y Zhong, D El-Gamal, JA Dubovsky, KA Beckwith, BK Harrington, ...
Leukemia, doi: 10.1038/leu.2014.9., 2014
强制性开放获取政策： US National Institutes of Health
Targeting Interleukin-2-inducible T-cell Kinase (ITK) and Resting Lymphocyte Kinase (RLK) Using a Novel Covalent Inhibitor PRN694.
Y Zhong, D S, S E, R L, B JP, T K, M A, P P, B JM, B A, O TD, V E, B KA, ...
J Biol Chem, 2015
强制性开放获取政策： US National Institutes of Health
PKC-β as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL
D El-Gamal, K Williams, TD LaFollette, M Cannon, JS Blachly, Y Zhong, ...
Blood, The Journal of the American Society of Hematology 124 (9), 1481-1491, 2014
强制性开放获取政策： US National Institutes of Health
The spectrum of rare central nervous system (CNS) tumors with EWSR1‐non‐ETS fusions: experience from three pediatric institutions with review of the literature
O Lopez‐Nunez, B Cafferata, M Santi, S Ranganathan, TM Pearce, ...
Brain pathology 31 (1), 70-83, 2021
强制性开放获取政策： Government of Italy
Targeting Interleukin-2-Inducible T-cell Kinase (ITK) in T-Cell Related Diseases
Y Zhong, AJ Johnson, JC Byrd, JA Dubovsky
Journal of Postdoctoral Research June 2 (6), 1-11, 2014
强制性开放获取政策： US National Institutes of Health
AP-1 elements and TCL1 protein regulate expression of the gene encoding protein tyrosine phosphatase PTPROt in leukemia
T Motiwala, N Zanesi, J Datta, S Roy, H Kutay, AM Checovich, M Kaou, ...
Blood, The Journal of the American Society of Hematology 118 (23), 6132-6140, 2011
强制性开放获取政策： US National Institutes of Health
Effect of increased HoxB4 on human megakaryocytic development
Y Zhong, B Sullenbarger, LC Lasky
Biochemical and biophysical research communications 398 (3), 377-382, 2010
强制性开放获取政策： US National Institutes of Health
Novel ATXN1/ATXN1L::NUTM2A fusions identified in aggressive infant sarcomas with gene expression and methylation patterns similar to CIC-rearranged sarcoma
F Xu, AN Viaene, J Ruiz, J Schubert, J Wu, J Chen, K Cao, W Fu, ...
Acta Neuropathologica Communications 10 (1), 102, 2022
强制性开放获取政策： US National Institutes of Health
Genomic characterization of a PPP1CB-ALK fusion with fusion gene amplification in a congenital glioblastoma
Y Zhong, F Lin, F Xu, J Schubert, J Wu, L Wainwright, X Zhao, K Cao, ...
Cancer Genetics 252, 37-42, 2021
强制性开放获取政策： US National Institutes of Health
A germline PALB2 pathogenic variant identified in a pediatric high-grade glioma
Y Zhong, J Schubert, J Wu, F Xu, F Lin, K Cao, K Zelley, M Luo, JB Foster, ...
Molecular Case Studies 6 (4), a005397, 2020
强制性开放获取政策： US National Institutes of Health
A novel ARIH1:: BRAF fusion in a glioma
E Xu, SL Stone, Y Zhong, N Golenberg, L Qiu, Z Abdullaev, K Aldape, ...
Journal of Neuropathology & Experimental Neurology 82 (11), 966-969, 2023
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定